{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:22:46Z","timestamp":1777526566478,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11060-019-03330-9","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T17:10:07Z","timestamp":1572973807000},"page":"581-585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases"],"prefix":"10.1007","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-4852","authenticated-orcid":false,"given":"Amelia","family":"Jardim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachery","family":"Drew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Foote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananthababu P.","family":"Sadasivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir","family":"Shanker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark B.","family":"Pinkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"3330_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12682","author":"M Tio","year":"2018","unstructured":"Tio M, Wang X, Carlino MS, Shivalingam B, Fogarty GB, Guminski AD, Lo S, Hong AM, Menzies AM, Long GV (2018) Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy. Pigment Cell Melanoma Res. \nhttps:\/\/doi.org\/10.1111\/pcmr.12682","journal-title":"Pigment Cell Melanoma Res."},{"issue":"4","key":"3330_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ijrobp.2017.06.2454","volume":"99","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M (2017) Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (Melanoma-molGPA). Int J Radiat Oncol Biol Phys 99(4):812\u2013816","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"3330_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(8):494\u2013500","journal-title":"N Engl J Med"},{"issue":"4","key":"3330_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","volume":"15","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, Yamanaka K, Sato Y, Jokura H, Yomo S, Nagano O, Kenai H, Moriki A, Suzuki S, Kida Y, Iwai Y, Hayashi M, Onishi H, Gondo M, Sato M, Akimitsu T, Kubo K, Kikuchi Y, Shibasaki T, Goto T, Takanashi M, Mori Y, Takakura K, Saeko N, Kunieda E, Aoyama H, Momoshima S, Tsuchiya K (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15(4):387\u2013395","journal-title":"Lancet Oncol"},{"issue":"2","key":"3330_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.radonc.2018.08.018","volume":"129","author":"H Aiyama","year":"2018","unstructured":"Aiyama H, Yamamoto M, Kawabe T, Watanabe S, Koiso T, Sato Y, Higuchi Y, Ishikawa E, Yamamoto T, Matsumura A, Kasuya H, Barfod BE (2018) Complications after stereotactic radiosurgery for brain metastases: incidences, correlating factors, treatments and outcomes. Radiother Oncol 129(2):364\u2013369","journal-title":"Radiother Oncol"},{"issue":"2","key":"3330_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1515\/raon-2017-0018","volume":"51","author":"M Harat","year":"2017","unstructured":"Harat M, Lebioda A, Lasota J, Makarewicz R (2017) Evaluation of brain edema formation defined by MRI after LINAC-based stereotactic radiosurgery. Radiol Oncol 51(2):137\u2013141","journal-title":"Radiol Oncol"},{"issue":"5","key":"3330_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","volume":"19","author":"GV Long","year":"2018","unstructured":"Long GV, Atkinson V, Lo S, Sandhu S, Guminski AD, Brown MP, Wilmott JS, Edwards J, Gonzalez M, Scolyer RA, Menzies AM, McArthur GA (2018) Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol 19(5):672\u2013681","journal-title":"Lancet Oncol"},{"issue":"1","key":"3330_CR8","first-page":"43","volume":"4","author":"RJ Colaco","year":"2016","unstructured":"Colaco RJ, Yu JB, Bond JS, Bindra RS, Contessa JN, Knisely JPS, Chiang VL (2016) A contemporary dose selection algorithm for stereotactic radiosurgery in the treatment of brain metastases\u2014An initial report. J Radiosurg SBRT 4(1):43\u201345","journal-title":"J Radiosurg SBRT"},{"key":"3330_CR9","unstructured":"National Institute of Health- Cancer Therapy Evaluation Program (2017) Common Terminology Criteria for Adverse Events (CTCAE) v5.0 %3c\nhttps:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf\n\n%3e"},{"key":"3330_CR10","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/01.STR.27.8.1304","volume":"27","author":"RU Kothari","year":"2018","unstructured":"Kothari RU, Brott T, Broderick JP, Brasan WG, Sauerbeck LR, Zuccarello M, Khoury J (2018) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304\u20131305","journal-title":"Stroke"},{"key":"3330_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309845","author":"K Krishnan","year":"2015","unstructured":"Krishnan K, Mukhtar SF, Lingard J (2015) Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the efficacy of nitric oxide in stroke (ENOS) trial. J Neurol Neurosurg Psychiatry. \nhttps:\/\/doi.org\/10.1136\/jnnp-2014-309845","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"7","key":"3330_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","volume":"18","author":"MA Davies","year":"2017","unstructured":"Davies MA, Saiag P, Robert C, Grob JJ, Flaherty KT, Arance A, Chiarion-Sileni V, Thomas L, Lesimple T, Mortier L, Moschos SJ, Hogg D, M\u00e1rquez-Rodas I, Del Vecchio M, Lebb\u00e9 C, Meyer N, Zhang Y, Huang Y, Mookerjee B, Long GV (2017) Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Lancet Oncol 18(7):863\u2013873","journal-title":"Lancet Oncol"},{"key":"3330_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11060-015-2034-4","volume":"127","author":"A Hanna","year":"2016","unstructured":"Hanna A, Boggs DH, Kwok Y, Simard M, Regine WF, Mehta M (2016) What predicts early volumetric oedema increase following stereotactic radiosurgery for brain metastases? J Neurooncology. 127:303\u2013311","journal-title":"J Neurooncology."},{"issue":"19","key":"3330_CR14","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1002\/cncr.30138","volume":"122","author":"JM Qian","year":"2016","unstructured":"Qian JM, Yu JB, Kluger HM, Chiang VL (2016) Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery. Cancer 122(19):3051\u20133058","journal-title":"Cancer"},{"issue":"4","key":"3330_CR15","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","volume":"95","author":"G Minniti","year":"2016","unstructured":"Minniti G, Scaringi C, Paolini S, Lanzetta G, Romano A, Cicone F, Osti M, Enrici RM, Esposito V (2016) Single-fraction versus multifraction (3 \u00d7 9 Gy) stereotactic radiosurgery for large (%3e2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys 95(4):1142\u20131148","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3330_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/pcmr.12775","volume":"32","author":"I Pires da Silva","year":"2019","unstructured":"Pires da Silva I, Glitza IC, Haydu LE, Johnpulle R, Banks PD, Grass GD, Goldinger SMA, Smith JL, Everett AS, Koelblinger P, Roberts-Thomson R, Millward M, Atkinson VG, Guminski A, Kapoor R, Conry RM, Carlino MS, Wang W, Shackleton MJ, Eroglu Z, Lo S, Hong AM, Long GV, Johnson DB, Menzies AM (2019) Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies. Pigment Cell Melanoma Res 32(4):553\u2013563","journal-title":"Pigment Cell Melanoma Res"},{"issue":"8","key":"3330_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1470-2045(18)30439-X","volume":"19","author":"TJ Kruser","year":"2018","unstructured":"Kruser TJ, Gondi V, Sperduto PW, Brown PD (2018) Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation. Lancet Oncol 19(8):366","journal-title":"Lancet Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-019-03330-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:27:49Z","timestamp":1604449669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-019-03330-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3330"],"URL":"https:\/\/doi.org\/10.1007\/s11060-019-03330-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"6 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patient data was de-identified prior to review and its use approved by Institutional Review Board from the Princess Alexandra Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics approval to conduct research at the Princess Alexandra Hospital was granted by the Centers for Health Research on the 18\/07\/2017. The approval was subject to researcher compliance throughout the duration of the research with requirements as outlines in the National Statement on Ethical Conduct in Human Research 2007 and Australian Code for the Responsible Conduct of Research. HREC\/17\/QPAH\/379-SSA\/17\/QPAH\/380","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}